Skip to main content

carenity.com

carenity.com had about 369.64K visits in September 2026, up 6.86% from August; most traffic is search.

Maladies, symptômes et traitements sur Carenity

Traffic

369.64K

+6.86%MoMEstimated monthly visits
789447.44K298.3K149.15K0
Global rank

141,766

Country rank · France

5,628

Category rank · Health Conditions and Concerns

3

Average visit duration

01:25

Pages per visit

1.91

Bounce rate

52.17%

Domain age

16 years

Search share

54.3%

Traffic sources

  • Search
    54.3%
  • Email
    25.1%
  • Direct
    16.0%
  • Referrals
    3.3%
  • Paid search
    0.7%
  • Social
    0.4%
  • Display ads
    0.2%
  • Generative AI
    0.1%
  • Other
    0.0%

Regions

  • France
    83.8%
  • Belgium
    2.5%
  • United States
    2.1%
  • Canada
    1.9%
  • Algeria
    1.7%

See how carenity.com compares with the most visited websites in the world, the fastest growing websites and sites gaining organic search traffic.

Search visibility

Keyword samples

Estimated visitsMonthly searchesVisits ÷ searches
  1. arrêt venlafaxine témoignage660450147%
  2. ketoprofene5107.49K7%
  3. laroxyl49013.1K4%
  4. a molecule de la venlafaxine 37 5 est elle dure a arrete46078059%
  5. kesimpta avant après310—

Keyword rankings

Keyword rankings

Example · google.comUnited States · English

86.4M

Search estimate

New 1 · Up 2

Ranking keywords
12,400
Landing pages
4
Search competitors
4
AI citations
2
PositionEstimated visits
  1. google#142M
  2. gmail#118.2M
  3. google maps#19.4M
  4. google drive#14.1M

Full keyword rankings are a Pro feature

Unlock Pro

Baidu rank

Site profile

  • HTTP 200
  • Email authentication
  • Hosting ASN
HTTP
200
Page size
41.4 KiB
Hosting
AMAZON-02 · AS16509
Email authentication
SPF · DMARC quarantine
TLS
TLSv1.3 · 173 days
Page and SEOSchema 1
Title
Maladies, symptômes et traitements sur Carenity
Description
Echangez avec des personnes concernées par une maladie spécifique. ✓ 1er réseau social pour les patients et leurs proches. ✓ Des milliers de discussions.
Cross-origin redirect
Yes
Word count
709
Internal / external links
65 / 10
Language
fr-FR
H1 / H2
1 / 7
Images missing alt
8 / 26
Schema
Organization
Hreflang
de-de · en-gb · es-es · fr-fr · it-it · en-us
OG / Twitter
OG · Twitter
Technology and tracking1 tracking
Tracking clues
Google Tag Manager
Social links
facebook.com · instagram.com · youtube.com
Server
Apache/2.4.68 (Debian)
Security headers
3 / 6
HSTS / CSP
HSTS
Email and DNS securitySet
SPF
Set
DMARC
Set · quarantine
DKIM selectors
selector1
Mail stack
Microsoft 365
IPv6
No AAAA
Site verification TXT
Atlassian · Facebook · Google · Microsoft
SOA
ns1.gandi.net
NS
ns-166-b.gandi.net. · ns-232-c.gandi.net. · ns-131-a.gandi.net.
MX
1 carenity-com.mail.protection.outlook.com.
Hosting and networkAS16509
A
3.173.238.29 · 3.173.238.34 · 3.173.238.122 · 3.173.238.99
Hosting ASN
AS16509 · 3.173.238.0/24
Hosting organization
AMAZON-02 - Amazon.com, Inc.
Hosting country
US
BGP announcement
Yes
Reverse DNS
server-3-173-238-29.nrt20.r.cloudfront.net
TLS
TLSv1.3 · Verified
Certificate issuer
Amazon RSA 2048 M01
Certificate remaining
173 days
Certificate SAN
DNS:carenity.fr · DNS:*.carenity.fr · DNS:carenity.es · DNS:*.carenity.es · 6 more
robots and AI crawlingHTTP 200
Robots.txt
200
Global Disallow /
No
Sitemap
Index · 5
AI explicitly disallowed
0
AI explicitly allowed
0
Well-known public paths1 hits
Present / checked
1 / 5
/ads.txt
Present · 58 B

Website information

Domain
carenity.com
Registration status
Domain registered
Registered
2010-10-27
Registrar
Gandi SAS
Expires
2027-10-27
Domain age
16 years
DNSSEC
No
Registry status
client transfer prohibited

Similar sites

What's in this report

The report starts with a whole-site monthly visit estimate. Search visibility and public site facts follow when they exist.

  • Website traffic is a modeled whole-site estimate, with a source, observation period and confidence.
  • Search visibility is ranking keywords and search traffic, listed separately from whole-site visits.
  • Missing or partial values stay marked in the report.